Company intelligence / Profile preview

Cercle

San Francisco, California, United Statescercle.io ↗

Ownership: Private
Development stage: Commercial

Overview

Cercle has launched its AI-driven data analytics platform focused on transforming unstructured women’s healthcare data into actionable insights. The company is initially targeting fertility and reproductive health but plans to expand across other areas of women’s health. Its technology is already being used by major fertility networks and genetics labs to improve clinical outcomes and business operations for providers. No clinical trial results are reported as the company does not develop therapeutics.

Therapeutic areas: OncologyWomen's Health
Modalities: Not directly applicable (Cercle is a data/AI platform, not a therapeutics developer)
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

US Fertility (large network of fertility clinics)Eurofins Genoma (global DNA sequencing/genomics provider)

Beyond the preview

Go deeper on Cercle.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cercle.

Explore the full profile